– UK, Ashton-under-Lyne – Scapa Group plc (LON:SCPA) today announced that Joe Doherty, Sevan Demirdogen and Juliet Thompson have been appointed to the Board of Directors, with effect from 21 January 2019.
Larry Pentz, Scapa’s Chairman, said: “On behalf of the Board, I am delighted to welcome Joe, Sevan and Juliet to the Scapa Board of Directors. Their breadth of knowledge and experience will bring additional perspectives and depth to our Board while our business continues to grow and expand within the healthcare and industrial markets. The Board would like to thank Joe Davin, Healthcare President, whose leadership has taken our healthcare business from concept to a business with over £150 million revenue and recognised as a trusted strategic partner to many world leading healthcare companies.”
About Juliet Thompson
Juliet Thompson joins the Board as an Independent Non-Executive Director.
Juliet will chair the Remuneration Committee and will also be a member of the Board’s Audit and Risk, and Nomination Committees. Juliet is currently a board member of a number of internationally listed medical device, development and diagnostic companies, including being Non-Executive Director of Vectura Group plc, GI Dynamics Inc and Novacyt SA, and Deputy Chairman of Nexstim plc. She was previously Non-Executive Chairman and Director of the Board of Premier Veterinary Group plc until 1 March 2018. Juliet has spent over 20 years actively involved in the life sciences sector working as an investment banker and strategic advisor to healthcare companies in Europe. Juliet has a BSc in economics and is a chartered accountant.
About Joe Doherty
Joe Doherty joins the Board as an Executive Director and the Company as Healthcare President-Designate. Joe will become Healthcare President on 1 April 2019 following Joe Davin’s planned retirement on 31 March 2019.
Joe’s most recent role was President of Olympus Surgical Technologies America responsible for the strategic marketing, development and manufacturing of devices for a number of surgical specialties. He was also a member of the Olympus Corporation of the Americas Executive Committee. Prior to joining Olympus in 2015, Joe spent 24 years with Johnson & Johnson (J&J). During his tenure at J&J, Joe was Vice President of Integration, responsible for the largest acquisition in the company’s history (US$20bn acquisition of Synthes), and a member of the Executive Team of DePuy Synthes, a US$10bn orthopedic and neurosurgery device company. While at J&J, Joe was also Head of R&D and a member of the Neuro Franchise worldwide management board, responsible for the global neurosurgical/neurovascular portfolio of products. Joe is a graduate of the United States Military Academy (West Point), with a Bachelor of Science in Engineering, and has an MBA from Nichols College.
About Sevan Demirdogen
Sevan Demirdogen, current President and Executive Vice President of Scapa, joins the Board as an Executive Director.
Sevan joined Scapa in April 2018 from Illinois Tool Works (ITW) where he held various roles since 1982. During the past 10 years, Sevan has been the Group President of ITW Stokvis, one of the world’s largest independent tape converters with circa US$250m in revenue, responsible for 22 sites across 18 countries with over 1,000 employees.
For more information : http://www.scapa.com/en/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
